Skip to content
INNV

InnovAge Holding Corp.

InnovAge Holding Corp. Q1 FY2025 earnings call

November 5, 2024 · fiscal period ended 2024-09

EPS · actual vs est

/

Revenue · actual vs est

/
Ask about this call

Summary

Generated 2024-11-05

Management highlights

  • First quarter performance: Total revenues of $205.1 million, center level contribution margin of $34.5 million, and adjusted EBITDA of $6.5 million. - Leadership: Welcomed Michael Scarbrough as President and COO, and Chris Bent is leaving. - Employee engagement: Employee Engagement Score of 79% and Net Promoter Score reached 56. - Organic growth: Census increased to ~7,210, a 10% year-over-year growth. Sales and marketing strategies led to a 7% improvement in qualified lead volume. - Regulatory: CMS closed audit for Sacramento, state audits remain open for Sacramento and San Bernardino. - Clinical and operational: Progress in CVIs and OVIs to manage medical costs, labor efficiency, and risk score accuracy.
View in transcript ↓

Segment performance

Total revenues for the first fiscal quarter were $205.1 million. Center level contribution margin was $34.5 million, and adjusted EBITDA was $6.5 million. Compared to the first quarter of fiscal 2024, revenues increased by approximately 12% from $182.5 million and adjusted EBITDA increased by approximately 500% from $1.3 million. Census increased to approximately 7,210, representing a quarter-over-quarter improvement of approximately 3%.

View in transcript ↓

Guidance

  • Ending census for fiscal year 2025 expected between 7,300 and 7,750 participants. - Member months projected in range of 86,000 to 89,000. - Total revenue projected in range of $815 million to $865 million. - Adjusted EBITDA projected in range of $24 million to $31 million. - De novo losses for fiscal 2025 anticipated in $18 million to $20 million range.
View in transcript ↓

Risks

Forward-looking statements involve assumptions and are subject to risks and uncertainties. Risks discussed in Form 10-K annual report for fiscal year 2024 and subsequent SEC filings, including factors that can cause actual results to differ materially from expectations.

View in transcript ↓

Q&A highlights

Q: Jamie Perse asked about enrollment trends in states like Colorado, Sacramento, and Florida, and Florida market contribution.

A: Patrick Blair said there's positive momentum in all markets, some enrollment processing bottlenecks related to care assessments, but seeing signs of improvement in enrollment processing.

Q: Jared Haase asked about guidance assumptions and employee engagement.

A: Patrick Blair discussed gradual impact of risk pool rebalancing, Florida centers progressing as expected, and employee engagement driven by clear company objectives and recognition of heroic efforts.

Q: Matt Gilmore asked about clinical and operational initiatives.

A: Dr. Rich Feifer and Ben Adams discussed CVIs showing fast progress in inpatient reduction, OVIs focused on fleet, food service, and contact centers; Michael Scarbrough expected to drive further impact.

Q: Matt Gilmore followed up on EMR implementation.

A: Dr. Rich Feifer discussed EPIC implementation improving chronic condition recapture rates, aiding revenue accuracy and clinical programs.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS
Revenue

Transcript

November 5, 2024

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.